Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/87783
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBoardman, W.en
dc.contributor.authorLethbridge, M.en
dc.contributor.authorHampton, J.en
dc.contributor.authorSmith, I.en
dc.contributor.authorWoolnough, A.en
dc.contributor.authorMcEwen, M.en
dc.contributor.authorMiller, G.en
dc.contributor.authorCaraguel, C.en
dc.date.issued2014en
dc.identifier.citationJournal of wildlife diseases, 2014; 50(4):873-882en
dc.identifier.issn0090-3558en
dc.identifier.issn1943-3700en
dc.identifier.urihttp://hdl.handle.net/2440/87783-
dc.description.abstractAbstract We report the clinical course and physiologic and anesthetic data for a case series of 76 free-ranging dromedary camels (Camelus dromedarius) chemically restrained, by remote injection from a helicopter, in the rangelands of Western Australia and South Australia, 2008-11, to attach satellite-tracking collars. Fifty-five camels were successfully anesthetized using medetomidine-ketamine (MK, n = 27) and medetomidine-ketamine-butorphanol (MKB, n = 28); the induction of anesthesia in 21 animals was considered unsuccessful. To produce reliable anesthesia for MK, medetomidine was administered at 0.22 mg/kg (±SD = 0.05) and ketamine at 2.54 mg/kg (±0.56), and for MKB, medetomidine was administered at 0.12 mg/kg (±0.05), ketamine at 2.3 mg/kg (±0.39), and butorphanol at 0.05 mg/kg (±0.02). Median time-to-recumbency for MKB (8.5 min) was 2.5 min shorter than for MK (11 min) (P = 0.13). For MK, the reversal atipamezole was administered at 0.24 mg/kg (±0.10), and for MKB, atipamezole was administered at 0.23 mg/kg (±0.13) and naltrexone at 0.17 mg/kg (±0.16). Median time-to-recovery was 1 min shorter for MK (5 min) than MKB (6 min; P = 0.02). Physiologic parameters during recumbency were not clinically different between the two regimes. Both regimes were suitable to safely anesthetize free-ranging camels; however, further investigation is required to find the safest, most consistent, and logistically practical combination.en
dc.description.statementofresponsibilityWayne S. J. Boardman, Mark R. Lethbridge, Jordan O. Hampton, Ian Smith, Andrew P. Woolnough, Margaret-Mary McEwen, Graham W. J. Miller, and Charles G. B. Caraguelen
dc.language.isoenen
dc.publisherWildlife Disease Associationen
dc.rights© Wildlife Disease Association 2014en
dc.subjectAnesthesia; Camelus dromedarius; atipamezole; butorphanol; ketamine; medetomidine; naltrexoneen
dc.titleEvaluation of medetomidine-ketamine and medetomidine-ketamine-butorphanol for the field anesthesia of free-ranging dromedary camels (camelus dromedarius) in Australiaen
dc.typeJournal articleen
dc.identifier.rmid0030009618en
dc.identifier.doi10.7589/2014-03-059en
dc.identifier.pubid85566-
pubs.library.collectionAnimal and Veterinary Sciences publicationsen
pubs.library.teamDS04en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidBoardman, W. [0000-0002-1746-0682]en
dc.identifier.orcidSmith, I. [0000-0003-3813-2917]en
dc.identifier.orcidCaraguel, C. [0000-0003-0019-4813]en
Appears in Collections:Animal and Veterinary Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.